The treatment of dysmenorrhea with naproxen sodium: A report on two independent double-blind trials
References (17)
Lancet
(1953)- et al.
Relationship between inhibition of prostaglandin synthesis and drug efficacy: Support for the current theory on mode of action of aspirin-like drugs
Biochem. Biophys. Res. Commun
(1972) - et al.
The “Prostaglandin Step”, a bottleneck in the activation of the uterus
Life Sci
(1974) - et al.
The delay of spontaneous labor by naproxen in the rat model
Prostaglandins
(1973) - et al.
The role of estradiol 17β in the activation of the uterus during premature labor and the effect of naproxen, an inhibitor of prostaglandin synthesis
Prostaglandins
(1973) - et al.
Suppression of uterine activity and abortion by inhibition of prostaglandin synthesis
Prostaglandins
(1974) - et al.
The effect of the inhibition of prostaglandin synthesis on the intra-uterine pressure and clinical symptoms of dysmenorrheic patients
Prostaglandins
(1977) - et al.
Prostaglandins in endometrium and menstrual fluid from normal and dysmenorrheic subjects
Br. J. Obstet. Gynaecol
(1965)
There are more references available in the full text version of this article.
Cited by (76)
Primary dysmenorrhea: new dose of an old medicine offers more options
2020, Fertility and SterilityNonsteroidal antiinflammatory drugs and reproduction
1993, American Journal of Obstetrics and GynecologyDifferential response by adolescents to naproxen sodium therapy for spasmodic and congestive dysmenorrhea
1986, Journal of Adolescent Health Care
- ∗
Naproxen-sodium is the sodium salt of a-2-(6′-methoxy-2′ naphthyl)-propionic acid.
Copyright © 1977 Published by Mosby, Inc.